{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 8,
  "pageCount": 366,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a narrative structure to frame the drug's history as a series of red flags and industry failures.",
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/8",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-8",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The color was damaging, as it suggested that large players looked at licensing pitolisant 10-15 years ago and ran for the hills.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9cc8-de4cac523652",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.07,
        "y": 0.31
      },
      "kind": "paragraph",
      "text": "Other pharma companies tested pitolisant and their color is damning. We uncovered buried evidence that a number of major pharma companies synthesized pitolisant as a comparator and concluded that it suffers from cardiotoxicity and other fatal flaws.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19e70c60-39dc-445f-94d4-c184fb08ee8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "How did a random French lab’s molecule “work” where over a dozen major pharma companies failed? The elephant in the room: how did a small, troubled French lab miraculously “succeed,” when histamine H3 receptor antagonists/inverse agonists have a 40-year history of well-documented failure and toxicity.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61b08c0c-634c-4797-97d0-012acab0bb76",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.07,
        "y": 0.72
      },
      "kind": "paragraph",
      "text": "The early warning signs in Bioprojet’s pitolisant clinical development program. The first pitolisant patient data was published in 2007 and indicates two danger signals: 1) plasma levels of the drug were highly elevated... 2) the adverse event data indicated symptoms consistent with QT prolongation...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73cebc23-7341-46b5-96fa-631eb5fd080f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"There’s a piece of information. I know more than I’m telling you...I knew they had cardiovascular issues...that compound had issues...the main issue is it had a cardiovascular signal...I’m sure it was known as soon as people profiled it.\" — Senior scientist from Abbott, Johnson & Johnson, or GSK.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9cc8-e10678cb4f03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Executive summary (cont'd)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "048e0084-1853-42ca-828c-f0cb18e35760",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.61
      },
      "kind": "title",
      "text": "Part 2. Clinical evidence of pitolisant’s toxicity is overwhelming, with sham safety studies that misled the FDA into committing grave errors during its review. Adverse event reports indicate an unfolding tragedy.",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "491d2a24-b291-4a45-ba90-a3c2d6fd867d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.07,
        "y": 0.12
      },
      "kind": "title",
      "text": "Part 1. Pitolisant’s troubled history (cont’d)",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5dc9aa86-f4ab-42ca-b7f4-ae57d9c42aea",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "572c3984-8311-4d8a-94f2-382eaada7ac1",
      "evidence": "paragraph/paragraph: The early warning signs in Bioprojet’s pitolisant clinical development program.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 1,
      "beatId": "aac0dd07-d17f-4430-b8ac-8dd57ce646ce",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Setup & Stakes",
      "beatSlug": null,
      "evidence": "The document sets up the stakes by presenting the company's troubled history and the concerns over its drug and financial reporting",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}